NEW QIAstat-Dx Respiratory 2019-nCoV Panel 

NEW QIAstat-Dx Respiratory 2019-nCoV Panel 

December 18, 2020

To support the research efforts for accessible testing to meet the demands of the COVID-19 outbreak, QIAGEN® developed the QIAstat-Dx® Respiratory 2019-nCoV Panel. This version of our multiplex syndromic cartridge detects and differentiates 22 respiratory targets, including 2019-nCoV (SARS-CoV-2).

  • Includes 2 molecular targets specific to 2019-nCoV: ORF1b gene recommended by the Chinese Center for Disease Control and Prevention, and the E gene recommended by the US Centers for Disease Control and Prevention
  • Less than 1 minute hands-on time
  • Time to result: approximately 1 hour
HNPCC MASTR Plus new product release

HNPCC MASTR Plus new product release

Multiplicom is pleased to announce the release of the new updated HNPCC MASTR™ Plus molecular assay, research use only, for identification of all mutations in the coding region of MLH1, MSH2, MSH6, PMS2 and 3’ UTR of EPCAM genes.

April 22, 2015 More +
New MASTR Facility supports adoption of NGS

New MASTR Facility supports adoption of NGS

Multiplicom is pleased to announce the new MASTR Facility to enable the implementation of massively parallel sequencing capabilities in clinical genetics and pathology laboratories.

September 15, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us